For example, mutations in ATM, BRCA1 and BRCA2 increase the risk of breast cancer and ovarian cancer, while WT1 is commonly expressed in ovarian serous carcinomas and endometrial serous carcinoma and considered a diagnostic marker of these tumors40. This evidence concerns the gene BRCA1 and breast carcinoma.